Company news

OpSens Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Opsens Solutions Further Expands Intellectual Property Portfolio with USPTO Grant

June 11, 2019

Opsens Signs Landmark Supplier Agreement - Expands Optical Sensing Technology Impact Within Cardiology Segment

April 30, 2019

Opsens - Q2 2019 Revenues Reach $7.9 M, a 46% Increase

April 11, 2019

Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors

March 4, 2019

Opsens announces credit agreement with CIBC Innovation Banking

February 27, 2019

Opsens - Election results for the Board of directors

January 24, 2019

Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase

January 14, 2019

Opsens' dPR obtains CE marking to sell in Europe

January 9, 2019

UPDATE - Opsens reports Q4 and FY2018 results

November 28, 2018

Opsens receives Health Canada approval for dPR intended for the diagnosis of coronary stenosis with the heart at rest

November 27, 2018

Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest

November 8, 2018

Opsens - 50,000 patients diagnosed with the OptoWire

November 1, 2018

Opsens to Host Investor Webinar on Thursday, October 4 to Provide Update on Recent Developments

October 3, 2018

Opsens - New product for the diagnosis of coronary stenosis with the heart at rest

September 20, 2018

Opsens Reports Q3 2018 Results - Quarterly Revenues Eclipse $6.4 M

July 12, 2018

Opsens applauds Japanese government new regulation supporting diagnosis, such as FFR, before treatment of coronary stenosis

April 24, 2018

Opsens reports Q2 2018 results - Consolidated product sales up 44%

April 12, 2018

Opsens' technology granted FDA approval in Abiomed's Impella Cardiac Pump®

April 3, 2018

Opsens Reports Results of Shareholders Vote

January 31, 2018

Opsens Announces Election Results for the Board of Directors and the Retirement of Claude Belleville

January 23, 2018

Opsens Reports Q1 2018 Results - Record Quarterly Revenues With Growth in all Geographic Regions

January 15, 2018

Opsens' Japanese partner Zeon medical proceeds with Conversion of US$2 million Debenture

November 27, 2017

Opsens Reports 2017 Results - Consolidated Revenues Up 85% for Fiscal 2017

November 15, 2017

Opsens Gets Technological Award

October 24, 2017

Opsens Presents a Short Film at the International Medical Film Festival - Quebec in Good Health

September 13, 2017

Opsens Reports Q3 2017 Results - Another Record Quarter with Revenues Up 130% to $4.9 Million

June 29, 2017

Opsens - Robin Villeneuve Appointed as Chief Financial Officer

June 7, 2017

Opsens Inc. Presentation Now Available for On-Demand Viewing

May 16, 2017

Opsens to Webcast, Live, at Virtualinvestorconferences.com, May 11 at 1: 30 pm ET

May 8, 2017

Opsens Announces departure of CFO

May 5, 2017

Opsens Reports Q2 2017 Results - Quarterly Consolidated Revenues Up 75% to $4.8 Million

April 19, 2017

Opsens Announces Graduation to TSX

February 28, 2017

Opsens Reports Q1 2017 Results - Focused Execution Leads to Record Quarterly Revenues

January 26, 2017

Opsens Inc. completes a $14.95 million equity financing by way of prospectus

December 8, 2016

Opsens Inc. announces receipt for final short form prospectus

December 1, 2016

Opsens Inc. announces upsize to and provides additional details regarding its proposed equity financing

November 23, 2016

Opsens Announces Equity Financing

November 22, 2016

Opsens Reports Results for 2016 - Record Total Revenues Driven by Tenfold Increase in FFR Sales

November 16, 2016

Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication

September 26, 2016

Opsens announces partnership with Precise Downhole Services in the energy sector

September 22, 2016

Opsens Appoints Pat Mackin to its Board of Directors

September 7, 2016

Circulation Journal highlights OptoWire performance

August 15, 2016

Opsens Announces Fiscal 2016 Third Quarter Results - Sales of $2,125,000, up 156% Year-Over-Year

July 5, 2016

Opsens receives Health Canada approval for the sale of OptoWire II

June 22, 2016

Opsens completes $5 million private placement

May 17, 2016

Opsens announces results for its second quarter 2016

April 19, 2016

Opsens receives FDA 510(k) clearance for the OptoWire II

March 16, 2016

OPSENS named to the 2016 TSX Venture TOP 50®

March 8, 2016

Opsens hires George Quinoy as Vice President / General Manager U.S. Commercial Sales & Operations

January 25, 2016

Opsens reports Q1 2016 results

January 19, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 12 decks. Every deck is listed under its year.